Clinical trial · Interventional
Image Discovering Early Lung Cancer Project
Low-Dose Computed Tomography for Lung Cancer Screening in High Risk Asymptomatic Patients: the Taiwan Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lung cancer is the leading cause of cancer related death in Taiwan and world wide. The application of low dose helical computed tomography (CT) has been the milestone of lung cancer screening. Recently, The National Lung Screening Trial (NLST) shows screening with low-dose CT could reduce mortality from lung cancer. We conducted this clinical trial to determine the efficacy of low dose CT in early lung cancer screening in Taiwan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low-dose computed tomography (LDCT) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Low-dose computed tomography (LDCT)
- description
- Patients will have one baseline LDCT scan.
- interventionNames
- Procedure: Low-dose computed tomography (LDCT)
Primary outcomes (1)
- measure
- Lung cancer detection rate
- timeFrame
- 2 years
- description
- Assess number of lung cancer diagnoses after radiological and morphological verification of positive lung nodules.
Secondary outcomes (4)
- measure
- Lung cancer mortality
- timeFrame
- 5 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Age 50-74 years * 30 or more pack-years of cigarette smoking history * Former smokers: quit smoking within the previous 15 years * Ability to tolerate CT procedure * Signed informed consent Exclusion Criteria: * Severe uncontrolled heart, vascular, respiratory or endocrine pathology. * Life-expectancy less than 1 year * History of lung cancer * Acute respiratory disease * Hemoptysis. * Weight loss more than 6.8 kg in the 12 months prior to eligibility assessment * Participation in other cancer clinical trial * Chest CT examination in the 12 months prior to eligibility assessment.
References
Publications (0)
Data not yet available